Tower Research Capital LLC (Trc) Edgewise Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,676 shares of EWTX stock, worth $49,736. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,676
Previous 307
1097.39%
Holding current value
$49,736
Previous $8,000
1125.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding EWTX
# of Institutions
220Shares Held
98.2MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$203 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$121 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$83.3 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$81.4 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$67.7 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $855M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...